This use case focuses on:
Vital-sign patch protoptype: developing a prototype single-use vital-sign patch equipped with NB-IoT and/or LTE-M, to assess the technology’s suitability for single-use, direct-to-cloud vital-sign patches.
Localisable tag: developing accurate geo-location technology that could be applied to disposable vital-sign patches using (future versions of) narrow-band 3GPP mMTC technologies such as NB-IoT and LTE-M.
Locations: Oslo, Kongsberg, Norway
Dates: Q1-2021, Q3-2022
Partners involved: Philips, Oslo University Hospital
Funding reference: Horizon 2020; ICT-19-2019 - Advanced 5G validation trials across multiple vertical industries
Funding cycle: June 2019-November 2022